Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Bone Marrow Transplant
•
AML
What transplant conditioning regimen would you recommend for a pediatric patient with MDS and monosomy 7?
Related Questions
In what situations do you use G-CSF for patients undergoing allogeneic HSCT to facilitate engraftment?
How do you decide between HSCT and immunosuppressive therapy for treating hepatitis associated aplastic anemia?
What are your top takeaways in Hematologic Malignancies from ASH 2024?
Are there instances where you would use C5 complement inhibitors for isolated elevation of sc5b-9 in the absence of other TA-TMA features?
How do you approach autologous stem cell transplant in T-cell lymphomas/PTCL after induction chemotherapy with achievement of CR1?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
What therapy would you consider for refractory pediatric HR AML with KMT2Ar to try to induce remission for transplant?
How do you approach managing depression symptoms in patients who have had repeated high risk of bleeding?
How would you approach secondary stroke prevention in an adult with Hemoglobin SC disease?
